Editor's note: This story has been updated with information from Verily's announcement of the clearance.
Verily, the life sciences research subsidiary of Alphabet, has received FDA 510(k) clearance for an augmented version of its prescription Study Watch wearable that includes some form of arrhythmia monitoring.
The Study Watch With Irregular Pulse Monitor is classified by the FDA as a “...
San Francisco-based AliveCor announced that the FDA has granted its smartphone-enabled, single-channel ECG (electrocardiogram) recorder device over-the-counter (OTC) clearance. The company is now taking direct-to-consumer preorders for the device at a $199 pricepoint. It expects to begin shipping them in early March. Up until now the AliveCor device has only been made available to physicians and...
The FDA has granted a 510(K) Class II clearance to San Francisco-based AliveCor's iPhone-enabled heart monitor, which has been commonly known as the "iPhoneECG" since it first made an appearance at CES two years ago. The company announced the clearance as the mHealth Summit kicks off this week in the Washington DC area. AliveCor will begin pre-selling the $199 clinical-quality, ECG monitor,...
AT&T has inked a deal with eCardio Diagnostics to provide wireless connectivity to the arrhythmia monitoring company's near real-time cardiac monitoring devices. eCardio’s monitoring devices enable heart patients to recover at home rather than spend additional time in the hospital and aim to help reduce re-admissions among heart patients.
According to the companies' release, "eCardio has...
We reported earlier this week that Houston, TX-based wireless cardiac monitoring startup, eCardio had monitored about 20,000 patients to date. Today, CardioNet, one of the first wireless cardiac companies to go to market has announced that it just passed 300,000 patients monitored by its Mobile Cardiac Outpatient Telemetry (MCOT) service.
“With 300,000 patients having now benefited from our MCOT...
